Page last updated: 2024-08-24

fluorodeoxyglucose f18 and bay 86-7548

fluorodeoxyglucose f18 has been researched along with bay 86-7548 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barthe, N; Cazeau, AL; Fernandez, P; Hindié, E; Macgrogan, G; Morgat, C; Schollhammer, R; Vélasco, V; Vimont, D	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and bay 86-7548

Article	Year
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples. PloS one, 2019, Volume: 14, Issue:1 Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Lymphatic Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Bombesin; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies	2019

Article

Year

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.

PloS one, 2019, Volume: 14, Issue:1

Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Lymphatic Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Bombesin; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies

2019